What is NDC 67457-212?

67457-212 is the product NDC for Argatroban, Argatroban 250 mg/2.5mL injection, solution, listed with the FDA by Mylan Institutional LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Mylan Institutional LLC, NDC labeler code 67457. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Argatroban?

16 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Argatroban NDC 67457-212 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)67457-212Labeler and product segments. Claims need a package NDC.

Product NDC at billing width67457-0212Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
67457-212-02	6745702120267457021202	1 VIAL, GLASS in 1 CARTON (67457-212-02) / 2.5 mL in 1 VIAL, GLASSMarketed from Nov 14, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Argatroban
Generic name (nonproprietary): argatroban
Active ingredients: Argatroban — 250 mg/2.5mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Mylan Institutional LLCNDC labeler code 67457
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 202626
Marketing start: Nov 14, 2017
Listing expires: Dec 31, 2027
Other FDA classes: Thrombin Inhibitors (Mechanism)
Identifiers: Product ID 67457-212_08b6fbe4-ad4f-45eb-aad5-0b6bac026652SPL ID 08b6fbe4-ad4f-45eb-aad5-0b6bac026652SPL set ID b0dedf95-8395-46bf-b94a-dcf2dd085942RxCUI 308351UNII IY90U61Z3S
Pharmacologic class: Anti-coagulant; Direct Thrombin Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N467457021202 followed by a unit qualifier and the quantity

Package 67457-0212-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 15, 2025.

Indications (excerpt from the label)

Argatroban is a direct thrombin inhibitor indicated: • For prophylaxis or treatment of thrombosis in adult patients with heparin-induced thrombocytopenia (HIT) ( 1.1 ) • As an anticoagulant in adults patients with or at risk for HIT undergoing percutaneous coronary intervention (PCI) ( 1.2 ) 1.1 Heparin-Induced Thrombocytopenia Argatroban injection is indicated for prophylaxis or treatment of thrombosis in adult patients with heparin-induced thrombocytopenia (HIT). 1.2 Percutaneous Coronary Intervention Argatroban injection is indicated as an anticoagulant in adult patients with or at risk for HIT undergoing percutaneous coronary intervention (PCI).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 67457-212

What is NDC 67457-212?: 67457-212 is the product NDC for Argatroban, Argatroban 250 mg/2.5mL injection, solution, listed with the FDA by Mylan Institutional LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Argatroban.
What is the active ingredient?: Argatroban.
Who is the labeler?: Mylan Institutional LLC, NDC labeler code 67457. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Argatroban?: 16 other product NDCs are listed under this name. See all Argatroban NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Argatroban NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Argatroban	Argatroban 50 mg/50mL	InjectionIntravenous	Caplin Steriles Limited	65145-126	65145-0126-01
Argatroban	Argatroban 50 mg/50mL	InjectionIntravenous	Mullan Pharmaceutical Inc.	83301-0062	83301-0062-01
Argatroban	Argatroban 50 mg/50mL	InjectionIntravenous	Mullan Pharmaceutical Inc.	83301-0500	83301-0500-01
Argatroban	Argatroban 50 mg/50mL	Injection, SolutionIntravenous	Gland Pharma Limited	68083-568	68083-0568-01
Argatroban	Argatroban 1 mg/mL	InjectionIntravenous	Accord Healthcare Inc.	16729-430	16729-0430-1116729-0430-43
Argatroban	Argatroban 50 mg/50mL	InjectionIntravenous	Fresenius Kabi USA, LLC	65219-429	65219-0429-50
Argatroban	Argatroban 1 mg/mL	Injection, SolutionIntravenous	Sagent Pharmaceuticals	25021-414	25021-0414-50
Argatroban	Argatroban 50 mg/50mL	InjectionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9377	00143-9377-01
Argatroban	Argatroban 50 mg/50mL	Injection, SolutionIntravenous	Eugia US LLC	55150-241	55150-0241-0155150-0241-10
Argatroban	Argatroban 100 mg/mL	Injection, SolutionIntravenous	Amneal Pharmaceuticals LLC	70121-1037	70121-1037-01

All 17 Argatroban NDCs